Patients with inflammatory bowel disease are at increased risk for respiratory syncytial virus infection, according to new research presented at the 2023 annual meeting of the American College of Gastroenterology. Although patients with IBD are at an increased risk for developing respiratory infections, research has been limited on RSV in this setting, according to the researchers, led by Ryan A. Smith, MD, a gastroenterology fellow at the University of Wisconsin–Madison. He and his co-investigators wanted to evaluate whether patients with IBD are at an increased risk for RSV infection because that information can assist in informing appropriate vaccination strategies now…
Author: Abhay Panchal
AnX Robotica has announced the FDA clearance of NaviCam ProScan™, a groundbreaking AI-assisted reading tool for small bowel video capsule endoscopy. This clearance, achieved through the rigorous De Novo Submission Process, makes ProScan the first AI-assisted reading tool designed to aid in reviewing small bowel capsule endoscopy images for adult patients suspected of small bowel bleeding. ProScan leverages advanced AI technology to enhance the field of gastroenterology, enabling physicians to efficiently care for their patients. Dr. Cristiano Spada, a gastroenterology expert, praised this development as a significant advancement in small bowel capsule endoscopy, especially for patients with suspected gastrointestinal bleeding.…
EndoSound Inc., a medical technology company, has received 510(k) clearance from the FDA for its EndoSound Vision System® (EVS), a novel Endoscopic Ultrasound (EUS) device. This clearance, following the FDA’s Breakthrough Device designation in July 2021, marks a significant advancement in patient care. The EVS attaches to upper gastrointestinal endoscopes and integrates easily into existing endoscopy centers, making EUS more accessible and economical. It aims to shift the site of care to more efficient settings like ambulatory surgery centers (ASCs), preferred by patients, providers, and payers. The technology is recognized for its patient safety, cost reduction, and increased accessibility to…
HCP Live covers significant developments in the field of gastroenterology during December 2023. Key highlights include: American Gastroenterological Association (AGA) Guidelines: The AGA released two important guidelines in December. The first set of guidelines focuses on the use of biomarkers in managing Crohn’s Disease (CD), offering 11 conditional recommendations based on evidence and expert consensus. These guidelines emphasize the role of serum and fecal biomarkers as surrogates for endoscopic disease activity in CD. The second guideline pertains to the management of pouchitis and inflammatory pouch disorders, marking the first comprehensive evidence-based guideline in this area. Qazi Corner’s Fourth Installment: This…
Watch this amazing recap of The Scope Forward Show 2023 (Season 3). Risks in GI. Non-invasive testing. Breaking rules. Having a backup plan. Stool detection app. Reimbursement for AI. Self driving endoscopy. Lead, don’t get left behind. Endoscopy robots as part of the team. Value of data in GI. Precision medicine. Unconventional ideas. Thank YOU guests for the amazing work you do, for being so candid, and for making The Scope Forward Show one of the most influential podcasts in gastroenterology.
Cigna, which is the fourth largest insurer in the U.S. by membership size, is considering the sale of its Medicare Advantage business. Here are seven additional stories on the company that Becker’s has reported on since Nov. 2:
Join Tim O’Connell, a physician executive. In this episode, we explore the fascinating world of medical-grade AI and its transformative impact on health care. Tim provides valuable insights into the evolution of AI in medicine, recent advancements, and practical applications that are reshaping the future of patient care. Tim O’Connell is a physician executive.He discusses the KevinMD article, “The clinical AI revolution: 3 things to know.”
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a five-year, $3 million grant from the National Cancer Institute. The grant is aimed at developing artificial intelligence (AI) to detect and predict aggressive prostate cancer. This initiative is crucial in helping to avoid unnecessary treatments and their associated negative side effects. Key aspects of the project include: Addressing Overdiagnosis and Overtreatment: Prostate cancer is a common and serious health issue for men. Current screening and risk assessment methods often lead to overdiagnosis and overtreatment. Approximately 90% of people diagnosed with prostate cancer receive treatment, though up to…
The Becker’s ASC Review article explores the impact of artificial intelligence (AI) on Ambulatory Surgery Centers (ASCs) and healthcare in general. Key points from the article include: AI’s Growing Role in Healthcare: AI has seen a significant surge in healthcare over the past year, and surgery center leaders are closely monitoring its impact. The question is whether AI will make surgery centers more efficient or add complexity to their operations. Cautious Adoption of AI in Healthcare: Healthcare is traditionally slow to adopt new technologies due to high stakes and stringent regulations. Slim margins in the industry mean that every technology…
The article from The Medical Futurist outlines the significant milestones achieved in the field of artificial intelligence (AI) in medicine during 2023. Key highlights include: Rise of ChatGPT: In November 2022, OpenAI launched ChatGPT, a large language model that quickly gained popularity, reaching over 100 million users in just two months. This marked a significant shift in the public’s access to and interaction with AI, particularly in the medical field. Development of GPT-4: Following the success of ChatGPT, OpenAI released GPT-4, an even more advanced model. This development opened up new possibilities for future use cases in healthcare. Healthcare-Specific AI…